SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Liberty Media announced a proposed private offering of $600M in convertible senior notes with an option for an additional $90M. Net proceeds will be u...
Tenax Therapeutics reports that its Phase 3 LEVEL study for TNX-103 did not meet its primary endpoint, though exploratory analysis showed reduced NT-p...
Tonix Pharmaceuticals announced that TONMYA net sales increased 197% quarter-over-quarter to approximately $11 million. The company also reported appr...
MoonLake Immunotherapeutics reported positive results from its Phase 3 IZAR-1 trial for sonelokimab in psoriatic arthritis, alongside cash runway proj...
Sionna missed the key activity endpoint for the SION-719 proof-of-concept trial, canceling development as an add-on to Trikafta. Despite the setback, ...
Jade Biosciences reported positive Phase 1 data for JADE101 and announced the start of a Phase 2 trial, bolstered by robust cash reserves expected to ...
SIFCO Industries reported net sales of $26.1 million for Q3, up 18.3%, and net income of $4.4 million for the first nine months. The company achieved ...
AAON reported a 101% increase in Q2 net sales to a record $627 million, driven by demand and operational execution. The company raised its full-year 2...
Ceva Inc reported Q2 2026 financial results with total revenue up 13% and licensing revenues up 21%, the highest in three years, driven by demand for ...
News Corp updated its capital management strategy with a repurchase program. This action signals confidence in its financial performance and aims to e...
Shoulder Innovations, Inc. (SI) has promoted Jon Osborne to Chief Commercial Officer, effective August 6, 2026. This leadership change is a key strate...
OPAL Fuels reported second-quarter 2026 adjusted EBITDA of $39.8 million and confirmed it remains on track for its annual guidance despite flat RIN pr...
Institutional holdings report (13F-HR) filed by Arbiter Partners Capital Management LLC....
Aquestive Therapeutics announced positive human factors and pharmacokinetic study results for its Anaphylm (dibutepinephrine) sublingual film, support...
Village Farms International reported Q2 2026 results with a 27% sequential increase in net sales to $64 million and net income of $7.1 million, driven...
Axmore reported Q2 2026 financial results with AUVELITY and SUNOSI driving growth, alongside clinical advances in its neuroscience pipeline....
Target Hospitality announced second-quarter revenue of $85.5 million and significant growth in contract awards and liquidity. The company raised its f...
TPG Mortgage Investment Trust reported second quarter 2026 financial results, increasing book value and offering a dividend. The company also announce...
N-able reported Q2 2026 revenue of $138.2 million, representing 5.9% year-over-year growth and an updated ARR outlook of $562M to $565M....
Ceco Environmental reported record-setting second quarter 2026 results driven by a 191% increase in orders and growth ahead of expectations following ...